Published in J Mol Biol on August 14, 2010
Regulation of innate immunity through RNA structure and the protein kinase PKR. Curr Opin Struct Biol (2010) 1.29
Strategies for viral RNA stability: live long and prosper. Trends Genet (2011) 0.85
Analysis of PKR-RNA interactions by sedimentation velocity. Methods Enzymol (2011) 0.83
Specificity of the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR for double-stranded RNA: insights from thermodynamics and small-angle X-ray scattering. Biochemistry (2012) 0.82
Domain interactions in adenovirus VAI RNA mediate high-affinity PKR binding. J Mol Biol (2014) 0.80
The use of analytical sedimentation velocity to extract thermodynamic linkage. Biophys Chem (2011) 0.79
Structural analysis of adenovirus VAI RNA defines the mechanism of inhibition of PKR. Biophys J (2015) 0.77
Dissection of the adenoviral VA RNAI central domain structure reveals minimum requirements for RNA-mediated inhibition of PKR. J Biol Chem (2014) 0.77
Activation of PKR by short stem-loop RNAs containing single-stranded arms. RNA (2016) 0.76
Role of the Interdomain Linker in RNA-Activated Protein Kinase Activation. Biochemistry (2015) 0.76
Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol (2006) 5.48
Higher-order substrate recognition of eIF2alpha by the RNA-dependent protein kinase PKR. Cell (2005) 4.41
Interactions between double-stranded RNA regulators and the protein kinase DAI. Mol Cell Biol (1992) 4.16
Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol (2008) 4.16
Analysis of heterologous interacting systems by sedimentation velocity: curve fitting algorithms for estimation of sedimentation coefficients, equilibrium and kinetic constants. Biophys Chem (2004) 3.32
The characteristics of inhibition of protein synthesis by double-stranded ribonucleic acid in reticulocyte lysates. J Biol Chem (1975) 2.84
Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation. EMBO J (1998) 2.68
Minor-groove recognition of double-stranded RNA by the double-stranded RNA-binding domain from the RNA-activated protein kinase PKR. Biochemistry (1996) 2.65
The double-stranded-RNA-binding motif: interference and much more. Nat Rev Mol Cell Biol (2004) 2.50
Purification and activation of the double-stranded RNA-dependent eIF-2 kinase DAI. Mol Cell Biol (1989) 2.48
Improved methods for fitting sedimentation coefficient distributions derived by time-derivative techniques. Anal Biochem (2006) 2.36
Inhibition of PKR by RNA and DNA viruses. Virus Res (2006) 2.23
Interaction of adenovirus VA RNAl with the protein kinase DAI: nonequivalence of binding and function. Cell (1990) 1.90
Interferon action and the double-stranded RNA-dependent enzymes ADAR1 adenosine deaminase and PKR protein kinase. Prog Nucleic Acid Res Mol Biol (2006) 1.62
Effects of mutations in stem and loop regions on the structure and function of adenovirus VA RNAI. EMBO J (1988) 1.58
The regulation of the protein kinase PKR by RNA. Biochimie (1996) 1.45
Mechanism of PKR activation: dimerization and kinase activation in the absence of double-stranded RNA. J Mol Biol (2005) 1.44
Mechanism of PKR Activation by dsRNA. J Mol Biol (2008) 1.42
Activation of PKR: an open and shut case? Trends Biochem Sci (2006) 1.41
Concentration, compartmentation and metabolic function of intracellular free Mg2+. Magnes Res (2006) 1.29
Functional dissection of adenovirus VAI RNA. J Virol (1989) 1.26
Uncoupling of RNA binding and PKR kinase activation by viral inhibitor RNAs. J Mol Biol (2006) 1.18
RNA dimerization promotes PKR dimerization and activation. J Mol Biol (2009) 1.16
Analysis of PKR structure by small-angle scattering. J Mol Biol (2009) 1.14
Structural features of adenovirus 2 virus-associated RNA required for binding to the protein kinase DAI. Nucleic Acids Res (1994) 1.06
Role of the apical stem in maintaining the structure and function of adenovirus virus-associated RNA. J Virol (1992) 1.06
Mutational analysis of the central domain of adenovirus virus-associated RNA mandates a revision of the proposed secondary structure. J Virol (1993) 1.03
Systematic deletion of the adenovirus-associated RNAI terminal stem reveals a surprisingly active RNA inhibitor of double-stranded RNA-activated protein kinase. J Biol Chem (2008) 1.00
Viral dsRNA inhibitors prevent self-association and autophosphorylation of PKR. J Mol Biol (2007) 0.98
Effect of single-base substitutions in the central domain of virus-associated RNA I on its function. J Virol (1995) 0.96
Selective binding by the RNA binding domain of PKR revealed by affinity cleavage. Biochemistry (2001) 0.96
Secondary and tertiary structure in the central domain of adenovirus type 2 VA RNA I. RNA (1996) 0.96
Analysis of adenovirus VA RNAI structure and stability using compensatory base pair modifications. Nucleic Acids Res (2008) 0.89
Distinct contributions of T1R2 and T1R3 taste receptor subunits to the detection of sweet stimuli. Curr Biol (2005) 2.00
T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligand-binding surface. Immunity (2007) 1.92
Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid. J Biol Chem (2002) 1.80
Structure of the s5a:k48-linked diubiquitin complex and its interactions with rpn13. Mol Cell (2009) 1.57
General plasmids for producing RNA in vitro transcripts with homogeneous ends. Nucleic Acids Res (2003) 1.56
Recognition of C-terminal amino acids in tubulin by pore loops in Spastin is important for microtubule severing. J Cell Biol (2007) 1.56
Mechanism of PKR activation: dimerization and kinase activation in the absence of double-stranded RNA. J Mol Biol (2005) 1.44
Mechanism of PKR Activation by dsRNA. J Mol Biol (2008) 1.42
NTB-A receptor crystal structure: insights into homophilic interactions in the signaling lymphocytic activation molecule receptor family. Immunity (2006) 1.27
Domain architecture and biochemical characterization of vertebrate Mcm10. J Biol Chem (2007) 1.19
Structure of CD84 provides insight into SLAM family function. Proc Natl Acad Sci U S A (2007) 1.17
RNA dimerization promotes PKR dimerization and activation. J Mol Biol (2009) 1.16
Fluorescence stopped-flow studies of single turnover kinetics of E.coli RecBCD helicase-catalyzed DNA unwinding. J Mol Biol (2004) 1.16
Global analysis of non-specific protein-nucleic interactions by sedimentation equilibrium. Biophys Chem (2004) 1.14
Analysis of PKR structure by small-angle scattering. J Mol Biol (2009) 1.14
Determination of the target nucleosides for members of two families of 16S rRNA methyltransferases that confer resistance to partially overlapping groups of aminoglycoside antibiotics. Nucleic Acids Res (2009) 1.10
Defining how ubiquitin receptors hHR23a and S5a bind polyubiquitin. J Mol Biol (2007) 1.09
Mechanism of interaction of the double-stranded RNA (dsRNA) binding domain of protein kinase R with short dsRNA sequences. Biochemistry (2007) 1.08
Unactivated PKR exists in an open conformation capable of binding nucleotides. Biochemistry (2006) 1.06
Molecular recognition and modification of the 30S ribosome by the aminoglycoside-resistance methyltransferase NpmA. Proc Natl Acad Sci U S A (2014) 1.06
Interaction of the trp RNA-binding attenuation protein (TRAP) with anti-TRAP. J Mol Biol (2004) 1.05
Conserved nucleotides within the J domain of the encephalomyocarditis virus internal ribosome entry site are required for activity and for interaction with eIF4G. J Virol (2003) 1.03
Systematic deletion of the adenovirus-associated RNAI terminal stem reveals a surprisingly active RNA inhibitor of double-stranded RNA-activated protein kinase. J Biol Chem (2008) 1.00
Critical residues for cofactor binding and catalytic activity in the aminoglycoside resistance methyltransferase Sgm. J Bacteriol (2008) 0.99
The solution structure of a DNA*RNA duplex containing 5-propynyl U and C; comparison with 5-Me modifications. Nucleic Acids Res (2003) 0.99
The role of human Dicer-dsRBD in processing small regulatory RNAs. PLoS One (2012) 0.97
Domain stabilities in protein kinase R (PKR): evidence for weak interdomain interactions. Biochemistry (2008) 0.97
Structure of the thiostrepton resistance methyltransferase.S-adenosyl-L-methionine complex and its interaction with ribosomal RNA. J Biol Chem (2009) 0.96
Expression and purification of functional ligand-binding domains of T1R3 taste receptors. Chem Senses (2006) 0.95
Structural insights into the function of aminoglycoside-resistance A1408 16S rRNA methyltransferases from antibiotic-producing and human pathogenic bacteria. Nucleic Acids Res (2010) 0.95
Expression, purification and crystallization of adenosine 1408 aminoglycoside-resistance rRNA methyltransferases for structural studies. Protein Expr Purif (2010) 0.94
Are fluorescence-detected sedimentation velocity data reliable? Anal Biochem (2013) 0.92
Energetics of SecA dimerization. J Mol Biol (2011) 0.92
Analysis of high-affinity binding of protein kinase R to double-stranded RNA. Biochemistry (2012) 0.90
Analysis of adenovirus VA RNAI structure and stability using compensatory base pair modifications. Nucleic Acids Res (2008) 0.89
Conformational dynamics of the Rpt6 ATPase in proteasome assembly and Rpn14 binding. Structure (2013) 0.87
Heparin activates PKR by inducing dimerization. J Mol Biol (2011) 0.87
The PKR-binding domain of adenovirus VA RNAI exists as a mixture of two functionally non-equivalent structures. Nucleic Acids Res (2009) 0.86
Raman and Raman optical activity (ROA) analysis of RNA structural motifs in Domain I of the EMCV IRES. Nucleic Acids Res (2007) 0.85
Cis-acting ribozymes for the production of RNA in vitro transcripts with defined 5' and 3' ends. Methods Mol Biol (2012) 0.84
Analysis of PKR-RNA interactions by sedimentation velocity. Methods Enzymol (2011) 0.83
Optimization of a ribosomal structural domain by natural selection. Biochemistry (2006) 0.82
General protocols for preparation of plasmid DNA template, RNA in vitro transcription, and RNA purification by denaturing PAGE. Methods Mol Biol (2012) 0.82
Defining the Escherichia coli SecA dimer interface residues through in vivo site-specific photo-cross-linking. J Bacteriol (2013) 0.82
A Phase II trial of topotecan and gemcitabine in patients with previously treated, advanced nonsmall cell lung carcinoma. Cancer (2002) 0.82
Role of the PAS sensor domains in the Bacillus subtilis sporulation kinase KinA. J Bacteriol (2013) 0.81
Aminoglycoside resistance genes sgm and kgmB protect bacterial but not yeast small ribosomal subunits in vitro despite high conservation of the rRNA A-site. Res Microbiol (2008) 0.81
Domain interactions in adenovirus VAI RNA mediate high-affinity PKR binding. J Mol Biol (2014) 0.80
Analysis of monomeric and dimeric phosphorylated forms of protein kinase R. Biochemistry (2010) 0.80
Coevolution of protein and RNA structures within a highly conserved ribosomal domain. Chem Biol (2005) 0.80
Reduced sweetness of a monellin (MNEI) mutant results from increased protein flexibility and disruption of a distant poly-(L-proline) II helix. Chem Senses (2011) 0.79
Identification of new inhibitors of protein kinase R guided by statistical modeling. Bioorg Med Chem Lett (2011) 0.78
Plasmid template design and in vitro transcription of short RNAs within a "structure cassette" for structure probing experiments. Methods Mol Biol (2012) 0.78
Analysis of SecA dimerization in solution. Biochemistry (2014) 0.78
Recombinant RNA expression. Nat Methods (2007) 0.75
Preface. Methods Enzymol (2015) 0.75
Phase I trial of gemcitabine, administered as a standard and constant dose-rate infusion, in combination with paclitaxel in patients with advanced solid tumors (LOA-2). Am J Clin Oncol (2002) 0.75
Heterologous Escherichia coli expression, purification and characterization of the GrmA aminoglycoside-resistance methyltransferase. Protein J (2009) 0.75